Becky S. Bibby
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized Prostate Cancers Undergoing Androgen Deprivation Therapy With Radiation Therapy.
Journal: International journal of radiation oncology, biology, physics
Published: March 12, 2024
Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma.
Journal: British journal of cancer
Published: February 25, 2022
Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses.
Journal: Clinical and experimental medicine
Published: September 28, 2021
Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer.
Journal: BMC urology
Published: January 26, 2021
Lost in application: Measuring hypoxia for radiotherapy optimisation.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 22, 2020
Selection of endogenous control genes for normalising gene expression data derived from formalin-fixed paraffin-embedded tumour tissue.
Journal: Scientific reports
Published: June 16, 2020
Independence of HIF1a and androgen signaling pathways in prostate cancer.
Journal: BMC cancer
Published: February 06, 2020
Measurement of the acute metabolic response to hypoxia in rat tumours in vivo using magnetic resonance spectroscopy and hyperpolarised pyruvate.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: May 14, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026